SI-BONE Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 41/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 25.22.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
SI-BONE Inc's Score
Industry at a Glance
Industry Ranking
41 / 207
Overall Ranking
132 / 4563
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
9
analysts
Buy
Current Rating
25.222
Target Price
+32.75%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
SI-BONE Inc Highlights
StrengthsRisks
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 57.11% year-on-year.
Undervalued
The company’s latest PE is -39.94, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 41.74M shares, decreasing 8.47% quarter-over-quarter.
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Ticker SymbolSIBN
CompanySI-BONE Inc
CEOFrancis (Laura A)
Websitehttps://si-bone.com/
FAQs
What is the current price of SI-BONE Inc (SIBN)?
The current price of SI-BONE Inc (SIBN) is 20.360.
What is the symbol of SI-BONE Inc?
The ticker symbol of SI-BONE Inc is SIBN.
What is the 52-week high of SI-BONE Inc?
The 52-week high of SI-BONE Inc is 21.070.
What is the 52-week low of SI-BONE Inc?
The 52-week low of SI-BONE Inc is 12.495.
What is the market capitalization of SI-BONE Inc?
The market capitalization of SI-BONE Inc is 881.05M.
What is the net income of SI-BONE Inc?
The net income of SI-BONE Inc is -30.91M.
Is SI-BONE Inc (SIBN) currently rated as Buy, Hold, or Sell?
According to analysts, SI-BONE Inc (SIBN) has an overall rating of Buy, with a price target of 25.222.
What is the Earnings Per Share (EPS TTM) of SI-BONE Inc (SIBN)?
The Earnings Per Share (EPS TTM) of SI-BONE Inc (SIBN) is -0.510.